[1]黄小娜,黄艳君,邵东平.SARS-CoV-2对眼部的影响及其经眼途径传播的可能性[J].眼科新进展,2021,41(10):996-1000.[doi:10.13389/j.cnki.rao.2021.0210]
　HUANG Xiaona,HUANG Yanjun,SHAO Dongping.Ocular influence and possibility of ocular transmission of SARS-CoV-2[J].Recent Advances in Ophthalmology,2021,41(10):996-1000.[doi:10.13389/j.cnki.rao.2021.0210]
点击复制

SARS-CoV-2对眼部的影响及其经眼途径传播的可能性/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
41卷
期数:
2021年10期
页码:
996-1000
栏目:
文献综述
出版日期:
2021-10-05

文章信息/Info

Title:
Ocular influence and possibility of ocular transmission of SARS-CoV-2
作者:
黄小娜; 黄艳君; 邵东平
528200　广东省佛山市，南方医科大学附属南海医院眼科
Author(s):
HUANG Xiaona; HUANG Yanjun; SHAO Dongping
Department of Ophthalmology,Nanhai Hospital Affiliated to Southern Medical University,Foshan 528200,Guangdong Province,China
关键词:
SARS-CoV-2; 眼部表现; 结膜囊感染率; 眼途径传播
Keywords:
SARS-CoV-2;  ocular presentation;  conjunctival sac infection rate;  ocular transmission
分类号:
R777.3
DOI:
10.13389/j.cnki.rao.2021.0210
文献标志码:
A
摘要:
SARS-CoV-2引起的新型冠状病毒肺炎（COVID-19）已对全球构成重大的公共卫生威胁。SARS-CoV-2和SARS-CoV均属于人冠状病毒（HCoVs）β属，两者的基因组相似性高达79.6%，且均通过血管紧张素转换酶2（ACE-2）感染宿主细胞。目前已有研究表明，SARS-CoV-2感染与结膜炎具有一定相关性，SARS-CoV-2是否能经眼感染或传播的问题也备受关注，但目前尚缺乏其通过眼部组织感染的临床确诊病例和实验室证据。本文就SARS-CoV-2的病原学特点、流行病学特征、眼部表现及结膜囊病毒感染率作一综述，并对SARS-CoV-2经眼途径传播的可能性进行探讨。
Abstract:
The corona virus disease 2019（COVID-19）pandemic induced by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has become a major global public health threat. Both the SARS-CoV-2 and SARS-CoV etiologic agents belong to the subfamily of beta human coronavirus, and their genomic similarity is up to 79.6%. Both SARS-CoV and SARS-CoV-2 infect the host cell through angiotensin converting enzyme-2. At present, it has been shown that SARS-CoV-2 infection is associated with conjunctivitis. Therefore, that whether the SARS-COV-2 can be infected or transmitted through the eye is also of great concern, but it still a lack of clinically confirmed cases and laboratory evidence of its ocular transmission. This review focuses on the etiological characteristics, epidemiologic features, ocular presentation of SARS-CoV-2 and the conjunctival sac infection rate, and the possibility of SARS-CoV-2 transmission through the ocular tissue will be discussed.

参考文献/References:

［1］　World Health Organization.Infection prevention and control during health care when novel coronavirus(nCoV) infection is suspected interim guidance［S/OL］.［2020-01-25］.https://apps.who.int/iris/handle/10665/330674.
［2］　ZHU N,ZHANG D Y,WANG W L,LI X W,YANG B,SONG J D,et al.A novel coronavirus from patients with pneumonia in China,2019［J］.N Engl J Med,2020,382(8):727-733.
［3］　ZHOU P,YANG X L,WANG X G,HU B,ZHANG L,ZHANG W,et al.A pneumonia outbreak associated with a new coronavirus of probable bat origin［J］.Nature,2020,579(7798):270-273.
［4］　HOLMES K V.SARS-associated coronavirus［J］.N Engl J Med,2003,348(20):1948-1951.
［5］　LI W H,MICHAEL J M,VASILIEVA N,SUI J H,WONG S K,MICHAEL A B,et al.Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus［J］.Nature,2003,426(6965):450-454.
［6］　MARKUS H,KLEINE-WEBER H,SCHROEDER S,KRGER N,TANJA H,ERICHSEN S,et al.SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor［J］.Cell,2020,181(2):271-280.
［7］　LAN J,GE J W,YU J,SHAN S,ZHOU H,FAN S L,et al.Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor［J］.Nature,2020,581(787):215-220.
［8］　SHANG J,YE G,SHI K,WAN Y S,LUO C M,AIHARA H,et al.Structural basis of receptor recognition by SARS-CoV-2［J］.Nature,2020,581(787):221-224.
［9］　国家卫生健康委办公厅,国家中医药管理局办公室.新型冠状病毒肺炎诊疗方案(试行第八版)［EB/OL］.［ 2020-08-18］.http://www.nhc.gov.cn/xcs/zhengcwj/202008/0a7bdf12bd4b-46e5bd28ca7f9a7f5e5a.shtml.
National Health Commission of China,National Administration of traditional Chinese Medicine of China.Diagnosis and treatment plan of pneumonia with new coronavirus infection (trial version 8)［EB/OL］.［2020-08-18］.http://www.nhc.gov.cn/xcs/zhengcwj/202008/0a7bdf12bd4b46e5bd28ca7f9a7f5e5a. shtml.
［10］　WANG D,HU B,HU C,ZHU F,LIU X,ZHANG J,et al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan,China［J］.JAMA,2020,323(11):1061-1069.
［11］　YEO C,KAUSHAL S,YEO D.Enteric involvement of coronaviruses:is faecal-oral transmission of SARS-CoV-2 possible?［J］.Lancet Gastroenterol Hepatol,2020,5(4):335-337.
［12］　PATAN L,MOROTTI D,GIUNTA M R,SIGISMONDI C,PICCOLI M G,FRIGERIO L,et al.Vertical transmission of coronavirus disease 2019:severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019-positive mothers and neonates at birth［J］.Am J Obstet Gynecol MFM,2020,2(3):100145.
［13］　HUI K,CHEUNG M C,PERERA R,NG K C,BUI C,HO J,et al.Tropism,replication competence,and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva:an analysis in ex-vivo and in-vitro cultures［J］.Lancet Respir Med,2020,8(7):687-695.
［14］　CHENTOUFI A A,DASGUPTA G,NESBURN A B,BETTAHI I,BINDER N R,CHOUDHURY Z S,et al.Nasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization［J］.Clin Vaccine Immunol,2010,17(3):342-353.
［15］　BELSER J A,ROTA P A,TUMPEY T M.Ocular tropism of respiratory viruses［J］.Microbiol Mol Biol Rev,2013,77(1):144-156.
［16］　DENG W,BAO L,GAO H,XIANG Z,QIN C.Rhesus macaques can be effectively infected with SARS-CoV-2 via ocular conjunctival route［R］.bioRxiv.2020.DOI:https://doi.org/10.1101/2020.03.13.990036
［17］　PAULSEN F.Functional anatomy and immunological interactions of ocular surface and adnexa［J］.Dev Ophthalmol,2008,41(1):21-35.
［18］　SEAH I,ANDERSON D E,KANG A,WANG L,RAO P,YOUNG B E,et al.Assessing viral shedding and infectivity of tears in coronavirus disease 2019(COVID-19)patients［J］.Ophthalmology,2020,127(7):977-979.
［19］　柳林,孙琰,潘欣,沈炜,刘志勇,刘银平.SARS-CoV S蛋白功能性受体ACE2在人角膜、结膜中的表达［J］.中华实验眼科杂志,2004,22(6):561-564.
LIU L,SUN Y,PAN X,SHEN W,LIU Z Y,LIU Y P.Expression of SARS coronavirus S protein functional receptor-Angiotensin-converting enzyme 2 in human cornea and conjunctiva［J］.Chin J Exp Ophthalmol,2004,22(6):561-564.
［20］　STRAIN W D,CHATURVEDI N.The renin-angiotensin-aldosterone system and the eye in diabetes［J］.J Renin Angiotensin Aldosterone Syst,2002,3(4):243-246.
［21］　ZHOU L,XU Z,CASTIGLIONE G M,SOIBERMAN U S,EBERHART C G,DUH E J.ACE2 and TMPRSS2 are expressed on the human ocular surface,suggesting susceptibility to SARS-CoV-2 infection［J］.Ocul Surf,2020,18(4):537-544.
［22］　YUAN J,FAN D,XUE Z,QU J,SU J.Co-expression of mitochondrial genes and ACE2 in cornea involved in COVID-19［J］.Invest Ophthalmol Vis Sci,2020,61(12):13.
［23］　RABOUD J,SHIGAYEVA A,MCGEER A,BONTOVICS E,CHAPMAN M,GRAVEL D,et al.Risk factors for SARS transmission from patients requiring intubation:a multicentre investigation in Toronto,Canada［J］.PLoS One,2010,5(5):e10717.
［24］　TONG T,LAI T S.The severe acute respiratory syndrome coronavirus in tears［J］.Br J Ophthalmol,2005,89(3):392.
［25］　叶娅,宋艳萍,闫明,胡城,陈晓,喻娟,等.新型冠状病毒肺炎合并结膜炎三例［J］.中华实验眼科杂志,2020,38(3):242-244.
YE Y,SONG Y P,YAN M,HU C,CHEN X,YU J,et al.Novel coronavirus pneumonia combined with conjunctivitis:three cases report［J］.Chin J Exp Ophthalmol,2020,38(3):242-244.
［26］　GEMES-VILLAHOZ N,BURGOS-BLASCO B,GARCA-FEIJO J,SENZ-FRANCS F,ARRIOLA-VILLALOBOS P,MARTINEZ-DE-LA-CASA J M,et al.Conjunctivitis in COVID-19 patients:frequency and clinical presentation［J］.Graefes Arch Clin Exp Ophthalmol,2020,258(11):2501-2507.
［27］　LIM L W,TAN G S,YONG V,ANDERSON D E,LYE D C,YOUNG B,et al.Acute onset of bilateral follicular conjunctivitis in two patients with confirmed SARS-CoV-2 infections［J］.Ocul Immunol Inflamm,2020,28(8):1280-1284.
［28］　WU P,DUAN F,LUO C,LIU Q,QU X,LIANG L,et al.Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province,China［J］.JAMA Ophthalmol,2020,138(5):575-578.
［29］　XIA J,TONG J P,LIU M Y,SHEN Y,GUO D.Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection［J］.J Med Virol,2020,92(6):589-594.
［30］　XIE H T,JIANG S Y,XU K K,LIU X,XU B,WANG L,et al.SARS-CoV-2 in the ocular surface of COVID-19 patients［J］.Eye Vis (Lond),2020,7(1):23.
［31］　ZHOU Y Y,ZENG Y Y,TONG Y Q,CHEN C Z.Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva［DB/OL］.New York:bioRxiv，(2020-02-11)［2020-08-21］.https://www.medrxiv.org/content/10.1101/2020.02.11.20021956v1.
［32］　LIANG L,WU P.There may be virus in conjunctival secretion of patients with COVID-19［J］.Acta Ophthalmol,2020,98(3):223.
［33］　FANG Z,ZHANG Y,HANG C,AI J,LI S,ZHANG W.Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients［J］.J Infect,2020,81(1):147-178.
［34］　CHEEMA M,AGHAZADEH H,NAZARALI S,TING A,HODGES J,MC F A,et al.Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19)［J］.Can J Ophthalmol,2020,55(4):125-129.
［35］　MARINHO P M,MARCOS A,ROMANO A C,NASCIMENTO H,BELFORT R J.Retinal findings in patients with COVID-19［J］.Lancet,2020,395(1237):1610.
［36］　LANDECHO M F,YUSTE J R,GNDARA E,SUNSUNDEGUI P,QUIROGA J,ALCAIDE A B,et al.COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?［J］.J Intern Med,2021,289(1):116-120.
［37］　ZIMMERMANN P,CURTIS N.Coronavirus infections in children including COVID-19:an overview of the epidemiology,clinical features,diagnosis,treatment and prevention options in children［J］.Pediatr Infect Dis J,2020,39(5):355-368.
［38］　CHIOTOS K,BASSIRI H,BEHRENS E M,BLATZ A M,CHANG J,DIORIO C,et al.Multisystem inflammatory syndrome in children during the coronavirus 2019 pandemic:a case series［J］.J Pediatric Infect Dis Soc,2020,9(3):393-398.
［39］　MA N,LI P,WANG X,YU Y,TAN X,CHEN P,et al.Ocular manifestations and clinical characteristics of children with laboratory-confirmed COVID-19 in wuhan,China［J］.JAMA Ophthalmol,2020,138(10):1079-1086.
［40］　CHEUNG E W,ZACHARIAH P,GORELIK M,BONEPARTH A,KERNIE S G,ORANGE J S,et al.Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York city［J］.JAMA,2020,324(3):294-296.
［41］　GODFREDCATO S,BRYANT B,LEUNG J,OSTER M E,CONKLIN L,ABRAMS J,et al.COVID-19-Associated multisystem inflammatory syndrome in children - United States,March-July 2020［J］.MMWR Morb Mortal Wkly Rep,2020,69(32):1074-1080.
［42］　MA N,LI P,WANG X,YU Y,TAN X,CHEN P,et al.Ocular manifestations and clinical characteristics of children with laboratory-confirmed COVID-19 in Wuhan,China［J］.JAMA Ophthalmol,2020,138(10):1079-1086.
［43］　LOFFREDO L,PACELLA F,PACELLA E,TISCIONE G,OLIVA A,VIOLI F.Conjunctivitis and COVID-19:a meta-analysis［J］.J Med Virol,2020,92(9):1413-1414.
［44］　ABRISHAMI M,TOHIDINEZHAD F,DANESHVAR R,OMIDTABRIZI A,AMINI M,SEDAGHAT A,et al.Ocular manifestations of hospitalized patients with COVID-19 in Northeast of Iran［J］.Ocul Immunol Inflamm,2020,28(5):739-744.
［45］　GAVRIILAKI E,BRODSKY R A.Severe COVID-19 infection and thrombotic microangiopathy:success doesn’t come easily［J］.Br J Haematol,2020,189(6):e227-e230.
［46］　李纯纯,唐媛,陈张艳,王爱孙,黄小琼,陈燕燕,等.非接触式眼压计测量产生气溶胶密度变化及其对新冠肺炎疫情防控的意义［J］.中华实验眼科杂志,2020,38(3):212-216.
LI C C,TANG Y,CHEN Z Y,WANG A S,HUANG X Q,CHEN Y Y,et al.Aerosol formation during non-contact “air-puff” tonometry and its significance for prevention of COVID-19［J］.Chin J Exp Ophthalmol,2020,38(3):212-216.

相似文献/References:

[1]王爱平.Moyamoya病相关眼部症状临床分析36例[J].眼科新进展,2012,32(8):000.

备注/Memo

备注/Memo:
N/A
更新日期/Last Update: 2021-10-05